Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Mangoceuticals, Inc. - Common Stock (NQ:MGRX)

1.750 -0.340 (-16.27%)
Streaming Delayed Price Updated: 11:04 AM EST, Nov 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 429,439
Open 1.800
Bid (Size) 1.750 (2,200)
Ask (Size) 1.760 (3,100)
Prev. Close 2.090
Today's Range 1.640 - 1.855
52wk Range 1.320 - 6.150
Shares Outstanding 10,535,791
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Consumer Staples Stocks Moving In Friday's After-Market Session
 
Via Benzinga
12 Consumer Staples Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga

Performance

YTD
-29.7%
-29.7%
1 Month
-30.8%
-30.8%
3 Month
+6.7%
+6.7%
6 Month
+1.7%
+1.7%
1 Year
-29.1%
-29.1%

More News

Read More
Top movers in Friday's after hours session
Via Chartmill
12 Consumer Staples Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Men's Telehealth Company's Plans To Change Men's Wellness
Via News Direct
MGRX Stock Earnings: Mangoceuticals Reported Results for Q2 2024
Via InvestorPlace
12 Consumer Staples Stocks Moving In Thursday's After-Market Session
Via Benzinga
Top stock movements in today's session.
Via Chartmill
Mangoceuticals Is Reengineering the Self-Care Blueprint with Better Personal Health and Wellness Solutions
Via ACCESS Newswire
Top movers in Wednesday's session
Via Chartmill
Top movers analysis in the middle of the day on 2025-04-23: top gainers and losers in today's session.
Via Chartmill
CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape
Via ACCESS Newswire
Top movers analysis one hour before the close of the markets on 2025-03-25: top gainers and losers in today's session.
Via Chartmill
Which stocks are experiencing notable movement on Tuesday?
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill
12 Consumer Staples Stocks Moving In Friday's After-Market Session
Via Benzinga
Top 3 Risk Off Stocks Which Could Rescue Your Portfolio This Quarter
Via Benzinga
12 Consumer Staples Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Consumer Staples Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Consumer Staples Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Consumer Staples Stocks Moving In Friday's After-Market Session
Via Benzinga
11 Consumer Staples Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Consumer Staples Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Consumer Staples Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Prescribing The Future: How MangoRx Is Shaking Up Telemedicine With A Fresh Platform
Via News Direct

Frequently Asked Questions

Is Mangoceuticals, Inc. - Common Stock publicly traded?
Yes, Mangoceuticals, Inc. - Common Stock is publicly traded.
What exchange does Mangoceuticals, Inc. - Common Stock trade on?
Mangoceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Mangoceuticals, Inc. - Common Stock?
The ticker symbol for Mangoceuticals, Inc. - Common Stock is MGRX on the Nasdaq Stock Market
What is the current price of Mangoceuticals, Inc. - Common Stock?
The current price of Mangoceuticals, Inc. - Common Stock is 1.750
When was Mangoceuticals, Inc. - Common Stock last traded?
The last trade of Mangoceuticals, Inc. - Common Stock was at 11/11/25 11:04 AM ET
What is the market capitalization of Mangoceuticals, Inc. - Common Stock?
The market capitalization of Mangoceuticals, Inc. - Common Stock is 18.44M
How many shares of Mangoceuticals, Inc. - Common Stock are outstanding?
Mangoceuticals, Inc. - Common Stock has 18M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.